Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 63 | 2021 | 2323 | 3.380 |
Why?
|
| Pulmonary Embolism | 18 | 2015 | 253 | 2.160 |
Why?
|
| Coronary Angiography | 31 | 2014 | 866 | 2.080 |
Why?
|
| Coronary Artery Disease | 16 | 2014 | 696 | 1.140 |
Why?
|
| Tomography, Spiral Computed | 5 | 2007 | 57 | 1.120 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 21 | 2014 | 373 | 0.970 |
Why?
|
| Pulmonary Artery | 6 | 2011 | 323 | 0.800 |
Why?
|
| Imaging, Three-Dimensional | 11 | 2013 | 333 | 0.700 |
Why?
|
| Contrast Media | 19 | 2015 | 594 | 0.670 |
Why?
|
| Cloud Computing | 1 | 2017 | 4 | 0.640 |
Why?
|
| Relative Value Scales | 1 | 2017 | 8 | 0.640 |
Why?
|
| Radiologists | 1 | 2017 | 35 | 0.610 |
Why?
|
| Efficiency, Organizational | 1 | 2017 | 61 | 0.610 |
Why?
|
| Workload | 1 | 2017 | 103 | 0.590 |
Why?
|
| Angiography | 6 | 2011 | 194 | 0.570 |
Why?
|
| Myocardial Perfusion Imaging | 5 | 2011 | 100 | 0.530 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2014 | 79 | 0.490 |
Why?
|
| Image Processing, Computer-Assisted | 8 | 2015 | 689 | 0.490 |
Why?
|
| Electrocardiography | 12 | 2014 | 601 | 0.460 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 4 | 2011 | 137 | 0.450 |
Why?
|
| Coronary Stenosis | 7 | 2010 | 246 | 0.440 |
Why?
|
| Radiation Dosage | 4 | 2011 | 419 | 0.420 |
Why?
|
| Sensitivity and Specificity | 20 | 2012 | 1753 | 0.420 |
Why?
|
| Heart Diseases | 3 | 2014 | 276 | 0.410 |
Why?
|
| Radiographic Image Enhancement | 11 | 2011 | 208 | 0.410 |
Why?
|
| Middle Aged | 47 | 2021 | 21119 | 0.410 |
Why?
|
| Radiography, Thoracic | 4 | 2005 | 99 | 0.410 |
Why?
|
| Algorithms | 10 | 2015 | 1194 | 0.380 |
Why?
|
| Humans | 76 | 2021 | 68525 | 0.370 |
Why?
|
| Coronary Disease | 6 | 2014 | 358 | 0.340 |
Why?
|
| Lung | 5 | 2004 | 849 | 0.340 |
Why?
|
| Risk Assessment | 7 | 2015 | 2004 | 0.340 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2007 | 75 | 0.320 |
Why?
|
| Chest Pain | 5 | 2014 | 151 | 0.310 |
Why?
|
| Male | 48 | 2021 | 37281 | 0.300 |
Why?
|
| Models, Statistical | 1 | 2011 | 446 | 0.300 |
Why?
|
| Coronary Vessels | 4 | 2015 | 313 | 0.290 |
Why?
|
| Female | 48 | 2016 | 38015 | 0.290 |
Why?
|
| Software | 5 | 2014 | 418 | 0.280 |
Why?
|
| Predictive Value of Tests | 10 | 2015 | 1465 | 0.270 |
Why?
|
| Calcinosis | 4 | 2012 | 241 | 0.270 |
Why?
|
| Bronchography | 1 | 2004 | 5 | 0.250 |
Why?
|
| Mediastinitis | 1 | 2004 | 4 | 0.250 |
Why?
|
| Bronchi | 1 | 2004 | 59 | 0.240 |
Why?
|
| Heart | 1 | 2008 | 850 | 0.230 |
Why?
|
| Reproducibility of Results | 15 | 2014 | 2077 | 0.230 |
Why?
|
| Aged | 25 | 2015 | 14842 | 0.230 |
Why?
|
| Exercise Test | 3 | 2014 | 242 | 0.220 |
Why?
|
| Ventricular Dysfunction, Right | 4 | 2015 | 117 | 0.220 |
Why?
|
| Myocardium | 1 | 2008 | 1204 | 0.220 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2002 | 8 | 0.210 |
Why?
|
| Emphysema | 1 | 2002 | 32 | 0.210 |
Why?
|
| Phantoms, Imaging | 3 | 2015 | 189 | 0.200 |
Why?
|
| Pneumonectomy | 1 | 2002 | 79 | 0.200 |
Why?
|
| Adult | 24 | 2016 | 21375 | 0.200 |
Why?
|
| Pattern Recognition, Automated | 3 | 2010 | 70 | 0.200 |
Why?
|
| Adipose Tissue | 2 | 2013 | 221 | 0.190 |
Why?
|
| Acute Disease | 8 | 2015 | 658 | 0.190 |
Why?
|
| Stents | 4 | 2015 | 657 | 0.190 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 1172 | 0.180 |
Why?
|
| Ventricular Function, Right | 2 | 2011 | 103 | 0.170 |
Why?
|
| Retrospective Studies | 16 | 2021 | 7264 | 0.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 300 | 0.160 |
Why?
|
| Iohexol | 4 | 2013 | 82 | 0.150 |
Why?
|
| Thrombophlebitis | 4 | 2004 | 47 | 0.150 |
Why?
|
| Myocardial Ischemia | 2 | 2008 | 172 | 0.150 |
Why?
|
| Hemangiosarcoma | 1 | 2016 | 23 | 0.140 |
Why?
|
| Cardiac-Gated Imaging Techniques | 3 | 2013 | 60 | 0.140 |
Why?
|
| Heart Neoplasms | 1 | 2016 | 33 | 0.140 |
Why?
|
| Artifacts | 4 | 2009 | 125 | 0.130 |
Why?
|
| Multidetector Computed Tomography | 2 | 2015 | 60 | 0.130 |
Why?
|
| Heart Atria | 1 | 2016 | 206 | 0.130 |
Why?
|
| Diagnosis, Differential | 5 | 2009 | 1139 | 0.130 |
Why?
|
| Diagnostic Errors | 2 | 2005 | 100 | 0.130 |
Why?
|
| Iopamidol | 3 | 2012 | 37 | 0.130 |
Why?
|
| Cardiovascular Diseases | 2 | 2014 | 938 | 0.130 |
Why?
|
| Hypertrophy, Right Ventricular | 2 | 2004 | 21 | 0.130 |
Why?
|
| Observer Variation | 5 | 2013 | 330 | 0.120 |
Why?
|
| Thoracic Diseases | 1 | 2014 | 10 | 0.120 |
Why?
|
| Cause of Death | 1 | 2015 | 241 | 0.120 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2014 | 35 | 0.120 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 2 | 2014 | 91 | 0.120 |
Why?
|
| Radiation Injuries | 1 | 2014 | 97 | 0.120 |
Why?
|
| Pulmonary Veins | 2 | 2004 | 56 | 0.120 |
Why?
|
| Vascular Stiffness | 1 | 2013 | 31 | 0.110 |
Why?
|
| Pericardium | 1 | 2013 | 97 | 0.110 |
Why?
|
| Patient Selection | 2 | 2007 | 592 | 0.110 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2014 | 125 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2015 | 232 | 0.110 |
Why?
|
| Chi-Square Distribution | 5 | 2012 | 546 | 0.110 |
Why?
|
| Statistics, Nonparametric | 5 | 2012 | 306 | 0.110 |
Why?
|
| Blood Volume | 1 | 2011 | 47 | 0.100 |
Why?
|
| Aged, 80 and over | 7 | 2009 | 4843 | 0.100 |
Why?
|
| Body Burden | 1 | 2011 | 27 | 0.100 |
Why?
|
| Coronary Circulation | 1 | 2011 | 136 | 0.100 |
Why?
|
| Perfusion Imaging | 1 | 2010 | 27 | 0.100 |
Why?
|
| Severity of Illness Index | 5 | 2015 | 1851 | 0.100 |
Why?
|
| Synovial Cyst | 2 | 1981 | 4 | 0.100 |
Why?
|
| Equipment Design | 2 | 2010 | 500 | 0.090 |
Why?
|
| Gout | 2 | 1981 | 9 | 0.090 |
Why?
|
| Adenosine | 1 | 2010 | 165 | 0.090 |
Why?
|
| Professional Competence | 1 | 2011 | 100 | 0.090 |
Why?
|
| Radionuclide Imaging | 2 | 2014 | 166 | 0.090 |
Why?
|
| Knee Joint | 2 | 1981 | 115 | 0.090 |
Why?
|
| Regression Analysis | 4 | 2013 | 737 | 0.090 |
Why?
|
| Hemodynamics | 2 | 2008 | 705 | 0.080 |
Why?
|
| Papillary Muscles | 1 | 2008 | 30 | 0.080 |
Why?
|
| Triiodobenzoic Acids | 1 | 2008 | 28 | 0.080 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2008 | 15 | 0.080 |
Why?
|
| Heart Valve Diseases | 1 | 2009 | 123 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2007 | 652 | 0.080 |
Why?
|
| Thrombosis | 1 | 2009 | 218 | 0.080 |
Why?
|
| Heart Rate | 1 | 2010 | 568 | 0.080 |
Why?
|
| Creatinine | 1 | 2008 | 243 | 0.080 |
Why?
|
| Heart Valve Prosthesis | 1 | 2009 | 222 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2011 | 2356 | 0.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2009 | 164 | 0.080 |
Why?
|
| Thrombolytic Therapy | 2 | 2009 | 233 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 1 | 2008 | 274 | 0.080 |
Why?
|
| Radiopharmaceuticals | 2 | 2021 | 114 | 0.070 |
Why?
|
| Lung Diseases | 2 | 2005 | 175 | 0.070 |
Why?
|
| Ventricular Function | 1 | 2007 | 93 | 0.070 |
Why?
|
| Emergency Medical Services | 1 | 2009 | 225 | 0.070 |
Why?
|
| Radiation Protection | 1 | 2007 | 71 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2008 | 167 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2008 | 204 | 0.070 |
Why?
|
| Pilot Projects | 3 | 2021 | 1341 | 0.070 |
Why?
|
| Syringes | 1 | 2006 | 15 | 0.070 |
Why?
|
| Sodium Chloride | 1 | 2006 | 136 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2008 | 307 | 0.070 |
Why?
|
| Syncope, Vasovagal | 1 | 2004 | 5 | 0.060 |
Why?
|
| Triage | 1 | 2005 | 109 | 0.060 |
Why?
|
| Dilatation, Pathologic | 1 | 2004 | 58 | 0.060 |
Why?
|
| Syncope | 1 | 2004 | 23 | 0.060 |
Why?
|
| Opportunistic Infections | 1 | 2004 | 33 | 0.060 |
Why?
|
| Blood Gas Analysis | 1 | 2004 | 41 | 0.060 |
Why?
|
| Aerospace Medicine | 1 | 2004 | 22 | 0.060 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2004 | 57 | 0.060 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2004 | 50 | 0.060 |
Why?
|
| Prognosis | 4 | 2015 | 2093 | 0.060 |
Why?
|
| Constriction, Pathologic | 1 | 2004 | 236 | 0.060 |
Why?
|
| Sarcoma, Synovial | 1 | 2003 | 11 | 0.060 |
Why?
|
| Isotopes | 1 | 2003 | 15 | 0.060 |
Why?
|
| Helium | 1 | 2003 | 9 | 0.060 |
Why?
|
| Myocardial Contraction | 1 | 2004 | 383 | 0.060 |
Why?
|
| Pulmonary Circulation | 1 | 2003 | 79 | 0.060 |
Why?
|
| Fibrosis | 1 | 2004 | 371 | 0.050 |
Why?
|
| Thrombectomy | 1 | 2005 | 238 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2004 | 453 | 0.050 |
Why?
|
| Venous Thrombosis | 1 | 2003 | 124 | 0.050 |
Why?
|
| Mass Screening | 1 | 2008 | 837 | 0.050 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2021 | 38 | 0.050 |
Why?
|
| Adolescent | 4 | 2009 | 8903 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 81 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2008 | 3185 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 2222 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 160 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2021 | 258 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2003 | 232 | 0.050 |
Why?
|
| Statistics as Topic | 2 | 2010 | 219 | 0.040 |
Why?
|
| Heart Failure | 1 | 2008 | 1179 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2015 | 714 | 0.040 |
Why?
|
| Biomarkers | 1 | 2004 | 1593 | 0.040 |
Why?
|
| Artificial Intelligence | 2 | 2011 | 159 | 0.040 |
Why?
|
| Risk Factors | 3 | 2014 | 5719 | 0.040 |
Why?
|
| ROC Curve | 2 | 2011 | 392 | 0.040 |
Why?
|
| Coronary Artery Bypass | 2 | 2011 | 218 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2011 | 3702 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 2 | 2009 | 503 | 0.040 |
Why?
|
| Hematemesis | 1 | 2016 | 14 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2011 | 791 | 0.040 |
Why?
|
| Hemoptysis | 1 | 2016 | 28 | 0.040 |
Why?
|
| Stochastic Processes | 1 | 2014 | 27 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2015 | 242 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2015 | 272 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 319 | 0.030 |
Why?
|
| Software Design | 1 | 2013 | 18 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2015 | 301 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2015 | 880 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2015 | 277 | 0.030 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2011 | 24 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 438 | 0.030 |
Why?
|
| Time Factors | 2 | 2011 | 4655 | 0.030 |
Why?
|
| Computer Systems | 1 | 2010 | 42 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1582 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 138 | 0.020 |
Why?
|
| Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography | 1 | 2009 | 2 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 1054 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 1037 | 0.020 |
Why?
|
| Metals | 1 | 2010 | 100 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2010 | 133 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2009 | 105 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 2 | 1981 | 155 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 765 | 0.020 |
Why?
|
| Warfarin | 1 | 2009 | 93 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 2008 | 21 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 1046 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2008 | 102 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2008 | 134 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2005 | 3256 | 0.020 |
Why?
|
| Movement | 1 | 2009 | 179 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 215 | 0.020 |
Why?
|
| Risk | 1 | 2008 | 563 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 237 | 0.020 |
Why?
|
| Bias | 1 | 2008 | 148 | 0.020 |
Why?
|
| Radiography | 1 | 2008 | 572 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1609 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 371 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2012 | 657 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2009 | 356 | 0.020 |
Why?
|
| Body Weight | 1 | 2008 | 554 | 0.020 |
Why?
|
| Logistic Models | 1 | 2009 | 1419 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 1039 | 0.020 |
Why?
|
| Calcium | 1 | 2009 | 929 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2005 | 87 | 0.020 |
Why?
|
| Life Tables | 1 | 2004 | 29 | 0.020 |
Why?
|
| Cardiac Catheterization | 1 | 2007 | 419 | 0.020 |
Why?
|
| Probability | 1 | 2005 | 244 | 0.020 |
Why?
|
| Granuloma | 1 | 2004 | 21 | 0.020 |
Why?
|
| Vascular Patency | 1 | 2004 | 122 | 0.020 |
Why?
|
| Aortography | 1 | 2004 | 72 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2009 | 7028 | 0.020 |
Why?
|
| South Carolina | 1 | 2011 | 2750 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2009 | 711 | 0.010 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2004 | 134 | 0.010 |
Why?
|
| Survival Rate | 1 | 2005 | 1055 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2008 | 2453 | 0.010 |
Why?
|
| Infant | 1 | 2008 | 2891 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 444 | 0.010 |
Why?
|
| Comorbidity | 1 | 2004 | 1425 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 5708 | 0.010 |
Why?
|
| Child | 1 | 2008 | 6400 | 0.010 |
Why?
|
| United States | 1 | 2008 | 7335 | 0.010 |
Why?
|
| Neoplasms | 1 | 2004 | 1660 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 20877 | 0.010 |
Why?
|